Resultados globales: 1 registros encontrados en 0.02 segundos.
Artículos, Encontrados 1 registros
Artículos Encontrados 1 registros  
1.
8 p, 264.9 KB A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Monoclonal Antibody MHAA4549A in Patients With Acute Uncomplicated Influenza A Infection / Lim, Jeremy J. (Early Clinical Development, Genentech, Inc) ; Dar, Sadia (Clinical Research Solutions, LLC) ; Venter, Dirk (Henderson Medical Centre) ; Horcajada, Juan Pablo (Institut Hospital del Mar d'Investigacions Mèdiques) ; Kulkarni, Priya (Early Clinical Development, Genentech, Inc) ; Nguyen, Allen (Early Clinical Development, Genentech, Inc) ; McBride, Jacqueline M. (Early Clinical Development, Genentech, Inc) ; Deng, Rong (Early Clinical Development, Genentech, Inc) ; Galanter, Joshua (Early Clinical Development, Genentech, Inc) ; Chu, Tom (Early Clinical Development, Genentech, Inc) ; Newton, Elizabeth M. (Early Clinical Development, Genentech, Inc) ; Tavel, Jorge A. (Early Clinical Development, Genentech, Inc) ; Peck, Melicent C. (Early Clinical Development, Genentech, Inc) ; Universitat Autònoma de Barcelona
MHAA4549A, a human monoclonal antibody targeting the influenza A hemagglutinin stalk, neutralizes influenza A virus in animal and human volunteer challenge studies. We investigated the safety and tolerability, efficacy, and pharmacokinetics of MHAA4549A in outpatients with acute, uncomplicated influenza A infection. [...]
2021 - 10.1093/ofid/ofab630
Open Forum Infectious Diseases, Vol. 9 (december 2021)  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.